Come up with a name for your new list and we'll add to it:
ImaginAb raised a round of funding on October 31, 2011. Investors include
National Cancer Institute.
ImaginAb is redefining therapeutic management by harnessing the power of antibody technology for in vivo imaging. The company's antibody fragment platform yields actionable molecular information to gu…